You are currently viewing a new version of our website. To view the old version click .

Antibiotics, Volume 8, Issue 3

September 2019 - 71 articles

Cover Story: The discovery of new antibiotics has drastically decreased in the last 30 years. Finding new classes of antimicrobials is a top priority in the fight against multidrug-resistant pathogens. Herein, we discuss a unique class of antimicrobials, the lasso peptides. We review lasso peptide biosynthesis, their antibiotic activity, and unique mechanisms of action. As interest in antimicrobial lasso peptides continues to grow, and further discovery and bio-engineering will facilitate their therapeutic and industrial commercialization. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (71)

  • Article
  • Open Access
12 Citations
5,138 Views
18 Pages

There is a scarcity of information on antibiotic resistance in goats. To understand shedding of resistant Escherichia coli in pastured goats, we collected fecal samples from a mixed age cohort over a one-year period. No antibiotic had been used on th...

  • Article
  • Open Access
3 Citations
5,401 Views
8 Pages

Female Asthmatic Patients Have Higher Risk to Develop Gemifloxacin-Associated Skin Rash, Highlighting Unique Delayed Onset Characteristics

  • Chiou-Mei Wu,
  • Po-Ju Wei,
  • Yu-Ting Shen,
  • Hsu-Liang Chang,
  • Ying-Ming Tsai,
  • Hung-Fang Pan,
  • Yong-Chieh Chang,
  • Yu-Ching Wei and
  • Chih-Jen Yang

Gemifloxacin is a common oral antibiotic for lower respiratory tract infection worldwide. We noticed an uncommon delayed onset skin rash in patients who received Gemifloxacin. Therefore, we retrospectively reviewed all patients who received Gemifloxa...

  • Review
  • Open Access
51 Citations
9,094 Views
16 Pages

Microbial natural product drug discovery and development has entered a new era, driven by microbial genomics and synthetic biology. Genome sequencing has revealed the vast potential to produce valuable secondary metabolites in bacteria and fungi. How...

  • Brief Report
  • Open Access
8 Citations
5,684 Views
5 Pages

Reduced Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in Cardiac Surgery Patients after Implementation of an Antimicrobial Stewardship Project

  • Daniele Roberto Giacobbe,
  • Antonio Salsano,
  • Filippo Del Puente,
  • Francesco Campanini,
  • Giovanni Mariscalco,
  • Anna Marchese,
  • Claudio Viscoli and
  • Francesco Santini

Infections due to carbapenem-resistant Klebsiella pneumoniae (CR-Kp) are associated with increased mortality in cardiac surgery patients. In this short communication, we report on the changes in the incidence of CR-Kp colonization and CR-Kp infection...

  • Article
  • Open Access
16 Citations
4,744 Views
8 Pages

Objectives: The ceragenins, or CSAs, were designed to mimic the activities of antimicrobial peptides and represent a new class of antimicrobial agent. The aim of this study was to comparatively investigate the antimicrobial activities of first/second...

  • Review
  • Open Access
122 Citations
13,337 Views
19 Pages

Phage Therapy with a Focus on the Human Microbiota

  • Sharita Divya Ganeshan and
  • Zeinab Hosseinidoust

Bacteriophages are viruses that infect bacteria. After their discovery in the early 1900s, bacteriophages were a primary cure against infectious disease for almost 25 years, before being completely overshadowed by antibiotics. With the rise of antibi...

  • Review
  • Open Access
47 Citations
9,465 Views
29 Pages

Staphylococcus aureus is an important nosocomial pathogen and its multidrug resistant strains, particularly methicillin-resistant S. aureus (MRSA), poses a serious threat to public health due to its limited therapeutic options. The increasing MRSA re...

  • Review
  • Open Access
23 Citations
8,395 Views
19 Pages

Direct Measurement of Performance: A New Era in Antimicrobial Stewardship

  • Majdi N. Al-Hasan,
  • Hana Rac Winders,
  • P. Brandon Bookstaver and
  • Julie Ann Justo

For decades, the performance of antimicrobial stewardship programs (ASPs) has been measured by incidence rates of hospital-onset Clostridioides difficile and other infections due to multidrug-resistant bacteria. However, these represent indirect and...

  • Review
  • Open Access
130 Citations
13,622 Views
16 Pages

The Perfect Bacteriophage for Therapeutic Applications—A Quick Guide

  • Lucía Fernández,
  • Diana Gutiérrez,
  • Pilar García and
  • Ana Rodríguez

The alarming spread of multiresistant infections has kick-started the quest for alternative antimicrobials. In a way, given the steady increase in untreatable infectious diseases, success in this endeavor has become a matter of life and death. Perhap...

of 8

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382